Metabolites of a tobacco-specific carcinogen in urine from newborns

Journal of the National Cancer Institute

Volumn 91, Issue 5, 1999, Pages 459-465

  Lackmann, Gerd M ^a   Salzberger, Ulrich ^b   Töllner, Uwe ^b   Chen, Menglan ^c   Carmella, Steven G ^c   Hecht, Stephen S ^c  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b KLINIKUM FULDA   (Germany)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; CARCINOGEN; COTININE; NICOTINE;

ARTICLE; CIGARETTE SMOKING; GAS CHROMATOGRAPHY; HUMAN; KIDNEY CONCENTRATING CAPACITY; MASS SPECTROMETRY; METABOLITE; NEWBORN; PREGNANCY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; TOBACCO; URINALYSIS; URINE;

EID: 0033518904     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.5.459     Document Type: Article

References (53)

1. Floyd RL, Rimer BK, Giovino GA, Mullen PD, Sullivan SE. A review of smoking in pregnancy: effects on pregnancy outcomes and cessation efforts. Annu Rev Public Health 1993; 14:379-411.
2. Walsh RA. Effects of maternal smoking on adverse pregnancy outcomes: examination of the criteria of causation. Hum Biol 1994;66: 1059-92.
3. Andres RL. The association of cigarette smoking with placenta previa and abruptio placentae. Semin Perinatol 1996;20:154-9.
4. Fingerhut LA, Kleinman JC, Kendrick JS. Smoking before, during, and after pregnancy. Am J Public Health 1990;80:541-4.
5. Byrd RS, Howard CR. Children's passive and prenatal exposure to cigarette smoke. Pediatric Annals 1995;24:640-5.
6. Coghlin J, Gann PH, Hammond SK, Skipper PL, Taghizadeh K, Paul M, et al. 4-Aminobiphenyl hemoglobin adducts in fetuses exposed to the tobacco smoke carcinogen in utero. J Natl Cancer Inst 1991;83:274-80
7. Myers SR, Spinnato JA, Pinorini-Godly MT, Cook C, Boles B, Rodgers GC. Characterization of 4-aminobiphenyl-hemoglobin adducts in maternal and fetal blood-samples. J Toxicol Environ Health 1996;47:553-66.
8. Pinorini-Godly MT, Myers SR. HPLC and GC/ MS determination of 4-aminobiphenyl haemoglobin adducts in fetuses exposed to the tobacco smoke carcinogen in utero. Toxicology 1996;107:209-17.
9. Everson RB, Randerath E, Santella RM, Cefalo RC, Avitts TA, Randerath K. Detection of smoking-related covalent DNA adducts in human placenta. Science 1986;231:54-7.
10. Everson RB, Randerath E, Santella RM, Avitts TA, Weinstein IB, Randerath K. Quantitative associations between DNA damage in human placenta and maternal smoking and birth weight. J Natl Cancer Inst 1988;80: 567-76.
11. 32P analysis of cigarette smoke-induced DNA damage in human tissues and mouse skin. Cancer Res 1986;46:5869-77.
12. Gallagher JE, Everson RB, Lewtas J, George M, Lucier GW. Comparison of DNA adduct levels in human placenta from polychlorinated biphenyl exposed women and smokers in which CYP 1A1 levels are similarly elevated. Teratog Carcinog Mutagen 1994;14:183-92.
13. Topinka J, Binkova B. Mrackova G, Stavkova Z, Peterka V, Benes I, et al. Influence of GSTM1 and NAT2 genotypes on placental DNA adducts in an environmentally exposed population. Environ Mol Mutagen 1997;30: 184-95.
14. Daube H, Scherer G, Riedel K, Ruppert T, Tricker AR, Rosenbaum P, et al. DNA adducts in human placenta in relation to tobacco smoke exposure and plasma antioxidant status. J Cancer Res Clin Oncol 1997;123:141-51.
15. Arnould JP. Verhoest P, Bach V, Libert JP, Belegaud J. Detection of benzo[a)pyrene-DNA adducts in human placenta and umbilical cord blood. Hum Exp Toxicol 1997;16: 716-21.
16. Shamsuddin AK, Gan R. Immunocytochemical localization of benzo[a]pyrene-DNA adducts in human tissues. Hum Pathol 1988;19: 309-15.
17. Hatch MC, Warburton D, Santella RM. Polycyclic aromatic hydrocarbon-DNA adducts in spontaneously aborted fetal tissues. Carcinogenesis 1990;11:1673-5.
18. Hansen C, Sorensen LD, Asmussen I, Autrup H. Transplacental exposure to tobacco smoke in human-adduct formation in placenta and umbilical cord blood vessels. Teratog Carcinog Mutagen 1992;12:51-60.
19. Manchester DK, Weston A, Choi JS, Trivers GE, Fennessey PV, Quintana E, et al. Detection of benzo[a]pyrene diol epoxide-DNA adducts in human placenta. Proc Natl Acad Sci USA 1988;85:9243-7.
20. Manchester DK, Bowman ED, Parker NB, Caporaso NE, Weston A. Determinants of polycyclic aromatic hydrocarbon-DNA adducts in human placenta [published erratum appears in Cancer Res 1992;52:3828]. Cancer Res 1992; 52:1499-503.
21. 6-methyl-deoxyguanosine in human placental DNA. Cancer Res 1988;48:4184-8.
22. Finette BA, O'Neill JP, Vacek PM, Albertini RJ. Gene mutations with characteristic deletions in cord blood T lymphocytes associated with passive maternal exposure to tobacco smoke. Nat Med 1998;4:1144-51.
23. Finette BA, Poseno T, Vacek PM, Albertini RJ. The effects of maternal cigarette smoke exposure on somatic mutant frequencies at the hprt locus in healthy newborns. Mutat Res 1997;377:115-23.
24. Correa E, Joshi PA, Castonguay A, Schuller HM. The tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is an active transplacental carcinogen in Syrian golden hamsters. Cancer Res 1990; 50:3435-8.
25. Schuller HM, Jorquera R, Reichert A, Castonguay A. Transplacental induction of pancreas tumors in hamsters by ethanol and the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res 1993;53: 2498-501.
26. Schuller HM, Jorquera R, Lu X. Riechert A, Castonguay A. Transplacental carcinogenicity of low doses of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone administered subcutaneously or intratracheally to hamsters. J Cancer Res Clin Oncol 1994;120:200-3.
27. Anderson LM, Hecht SS, Dixon DE, Dove LF, Kovatch RM, Amin S, et al. Evaluation of the transplacental tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mice. Cancer Res 1989;49:3770-5.
28. Beebe LE, Kim YE, Amin S, Riggs CW, Kovatch RM, Anderson LM. Comparison of transplacental and neonatal initiation of mouse lung and liver tumors by N-nitrosodimethyl-amine (NDMA) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and promotability by a polychlorinated biphenyls mixture (Aroclor 1254). Carcinogenesis 1993;14; 1545-8.
29. Hecht SS. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 1998;11:559-603.
30. Carmella SG, Akerkar S, Hecht SS. Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers' urine. Cancer Res 1993; 53:721-4.
31. Parsons WD, Carmella SG, Akerkar S, Bonilla LE, Hecht SS. A metabolite of the tobacco-specific lung carcinogen 4-(methylnitrosa-mino)-1-(3-pyridyl)-l-butanone in the urine of hospital workers exposed to environmental tobacco smoke. Cancer Epidemiol Biomarkers Prev 1998;7:257-60.
32. Curvall M, Elwin CE, Kazemi-Vala E, Warholm C, Enzell CR. The pharmacokinetics of cotinine in plasma and saliva from non-smoking healthy volunteers. Eur J Clin Pharmacol 1990;38:281-7.
33. 2 in humans. Biol Mass Spectrom 1991;20:247-52.
34. U.S. Department of Health and Human Services. Survey of compounds which have been tested for carcinogenic activity. Cumulative indexes. Bethesda (MD): National Institutes of Health; 1996 Report No. (NIH)96-149.
35. International Agency for Research on Cancer. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Man, Vol. 1. Lyon (France): IARC; 1972. p. 74-91.
36. Castonguay A, Tjalve H, Trushin N, Hecht SS. Perinatal metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in C57BL mice. J Natl Cancer Inst 1984;72:1117-26.
37. Rossignol G, Alaoui-Jamali MA, Castonguay A, Schuller HM. Metabolism and DNA damage induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in fetal tissues of the Syrian golden hamster. Cancer Res 1989;49: 5671-6.
38. Burchell B, Coughtrie M, Jackson M, Harding D, Fournel-Gigleux S, Leakey J, et al. Development of human liver UDP-glucuronosyl-transferases. Dev Pharmacol Ther 1989;13: 70-7.
39. Carmella SG, Akerkar S, Richie JP Jr, Hecht SS. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine. Cancer Epidemiol Biomarkers Prev 1995;4: 635-42.
40. Meger M, Meger-Kossien I, Dietrich M, Tricker AR, Scherer G, Adlkofer F. Metabolites of 4-(N-methylnitrosamino)-1-(3-pyridyl)-1-butanone in urine of smokers [published erratum appears in Eur J Cancer Prev 1997;6:99]. Eur J Cancer Prev 1996;5 Suppl 1:121-4.
41. Collins MD, Tzimas G, Hummler H, Burgin H, Nau H. Comparative teratology and transplacental pharmacokinetics of all-trans-retinoic acid, 13-cis-retinoic acid, and retinyl palmitate following daily administrations in rats. Toxicol Appl Pharmacol 1994;127:132-44.
42. Tzimas G, Collins MD, Nau H. Developmental stage-associated differences in the transplacental distribution of 13-cis- and all-trans-retinoic acid as well as their glucuronides in rats and mice. Toxicol Appl Pharmacol 1995;133: 91-101.
43. Etzel RA, Greenberg RA, Haley NJ, Loda FA. Urine cotinine excretion in neonates exposed to tobacco smoke products in utero. J Pediatr 1985;107:146-8.
44. Jordanov JS. Cotinine concentrations in amniotic fluid and urine of smoking, passive smoking and non-smoking pregnant women at term and in the urine of their neonates on 1st day of life. Eur J Pediatr 1990;149:734-7.
45. Luck W, Nau H, Hansen R, Steldinger R. Extent of nicotine and cotinine transfer to the human fetus, placenta and amniotic fluid of smoking mothers. Dev Pharmacol Ther 1985; 8:384-95.
46. Eliopoulos C, Klein J, Phan MK, Knie B, Greenwald M, Chitayat D, et al. Hair concentrations of nicotine and cotinine in women and their newborn infants. JAMA 1994;271:621-3.
47. Dempsey DA, Partridge JC, Jones RT, Rowbotham MC. Cocaine, nicotine, caffeine, and metabolite plasma concentrations in neonates. J Anal Toxicol 1998;22:220-4.
48. Hecht SS, Carmella SG, Chen M, Koch JF, Miller AT, Murphy SE, et al. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation. Cancer Res. In press.
49. Murphy SE, Carmella SG, Idris AM, Hoffmann D. Uptake and metabolism of carcinogenic levels of tobacco-specific nitrosamines by Sudanese snuff dippers. Cancer Epidemiol Biomarkers Prev 1994;3:423-8.
50. Everson RB. Individuals transplacentally exposed to maternal smoking may be at increased cancer risk in adult life. Lancet 1980;2: 123-7.
51. Tredaniel J, Boffetta P, Little J, Saracci R, Hirsch A. Exposure to passive smoking during pregnancy and childhood, and cancer risk: the epidemiological evidence. Paediatr Perinat Epidemiol 1994;8:233-55.
52. Thornton AJ, Lee PN. Parental smoking and risk of childhood cancer: a review of the evidence. Indoor Built Environ 1998;7:65-86.
53. Crawford FG, Mayer J, Santella RM, Cooper TB, Ottman R, Tsai WY, et al. Biomarkers of environmental tobacco smoke in preschool children and their mothers. J Natl Cancer Inst 1994;86:1398-402.